Free Trial

Mettler-Toledo International (NYSE:MTD) Given New $1,350.00 Price Target at Barclays

Mettler-Toledo International logo with Medical background

Key Points

  • Barclays has raised the price target for Mettler-Toledo International from $1,325.00 to $1,350.00, indicating a potential upside of 4.81% from the current stock price.
  • Five research analysts have rated Mettler-Toledo International with a Moderate Buy average rating, while the average target price stands at $1,328.33.
  • The company's recent quarterly earnings exceeded expectations, reporting $10.09 earnings per share against an anticipated $9.58, contributing to an overall revenue of $983.22 million.
  • MarketBeat previews the top five stocks to own by November 1st.

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price target hoisted by analysts at Barclays from $1,325.00 to $1,350.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an "overweight" rating on the medical instruments supplier's stock. Barclays's target price indicates a potential upside of 4.81% from the company's current price.

MTD has been the topic of several other reports. Bank of America increased their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. Citigroup raised their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Evercore ISI dropped their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research report on Monday, August 4th. Finally, Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $1,328.33.

Check Out Our Latest Report on MTD

Mettler-Toledo International Price Performance

Shares of NYSE MTD traded down $1.73 during mid-day trading on Thursday, reaching $1,288.09. The company's stock had a trading volume of 13,832 shares, compared to its average volume of 167,223. The stock has a fifty day moving average of $1,270.44 and a two-hundred day moving average of $1,185.39. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,488.75. The firm has a market capitalization of $26.53 billion, a PE ratio of 32.62, a P/E/G ratio of 3.68 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same period in the prior year, the business posted $9.65 earnings per share. The company's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Gerry Keller sold 165 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider directly owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,827 shares of company stock worth $2,371,208. Insiders own 1.94% of the company's stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors and hedge funds have recently modified their holdings of the company. Farther Finance Advisors LLC boosted its stake in Mettler-Toledo International by 39.1% in the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after acquiring an additional 25 shares in the last quarter. QRG Capital Management Inc. boosted its stake in shares of Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock worth $577,000 after buying an additional 111 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Mettler-Toledo International by 13.3% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock worth $2,929,000 after buying an additional 292 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after purchasing an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp raised its holdings in Mettler-Toledo International by 7.1% during the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after purchasing an additional 2,296 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Stories

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.